Pharmala Biotech Holdings Inc MDXXF
$0.19 $0.02 (12.35%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
MDXXF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Pharmala Biotech Holdings Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Pharmala Biotech Holdings Inc. Stock Analysis MDXXF
United States N/A Nano Cap PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. The company is headquartered in Toronto, Ontario. The company went IPO on 2022-01-11. The firm is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The firm has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. The company works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
Pharmala Biotech Holdings Inc (MDXXF) Chart
Financial Metrics & Statements of Pharmala Biotech Holdings Inc (MDXXF)
FAQ's for Pharmala Biotech Holdings Inc (MDXXF)
- As of August 2026, Pharmala Biotech Holdings Inc MDXXF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pharmala Biotech Holdings Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Pharmala Biotech Holdings Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Pharmala Biotech Holdings Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Pharmala Biotech Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Pharmala Biotech Holdings Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Pharmala Biotech Holdings Inc (MDXXF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
